PIM
SAGE

Partner Investment Management’s Sage Therapeutics SAGE Stock Holding History

Partner Investment Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-4,267
Closed -$599K – 62
2019
Q3 		$599K Buy
+4,267
New +$714K 1.06% 38
2019
Q2 		– Sell
-2,138
Closed -$340K – 98
2019
Q1 		$340K Sell
2,138
-4,046
-65% -$586K 0.48% 66
2018
Q4 		$592K Buy
+6,184
New +$708K 0.79% 45
2017
Q2 		– Sell
-1,572
Closed -$112K – 104
2017
Q1 		$112K Buy
+1,572
New +$92.1K 0.15% 89
2016
Q2 		– Sell
-4,201
Closed -$135K – 105
2016
Q1 		$135K Buy
+4,201
New +$148K 0.25% 73

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return